Navigation Links
CEL-SCI's Cel-1000 Shown to Significantly Enhance Immune Response,Against Hepatitis B Antigen in Animals

VIENNA, Va., May 01, 2007 /PRNewswire-FirstCall/ -- CEL-SCI CORPORATION announces that CEL-1000 alone increased the immune response against hepatitis B antigen, and that the combination of CEL-1000 with MAS-1, a proprietary water-in-oil adjuvant delivery system owned by Mercia Pharma, induced highly significant increases in specific anti-HBV (hepatitis B virus) antibodies. These findings were presented by Dr. Daniel Zimmerman, Senior Vice President of Research, Cellular Immunology at CEL-SCI at the 10th Annual Conference of the National Foundation for Infectious Diseases in Baltimore, Maryland.

This new finding with CEL-1000 may have broad application for the enhancement of immune responses by individuals who have a poor immune response to vaccinations. It also has application for antigen sparing (reducing the amount/dose of antigen) required for protective immunity, and application to biodefense and pandemic settings for anti-infectious vaccines.

Dr. Zimmerman said, "A good number of people, a great majority of them middle aged and older men, vaccinated against Hepatitis B fail to generate high enough levels of antibodies to be considered protected. These individuals need and deserve a better level of protection."

CEL-1000 has previously been shown to be protective in animal challenge studies against viruses and unrelated diseases, specifically herpes simplex virus, viral encephalitis and malaria. CEL-1000 appears to activate innate (very early stage) and Th1 type (cellular) immune responses to induce a broad- spectrum protection against infection in animal models. The innate immune system is generally accepted to be the first line of defense against infectious agents.

CEL-1000, derived from the beta chain of human MHC-II, is a modified version of a human immune-based protein known to bind to both human and mouse immune cells and appears to act by enhancing the host's protective imm
'"/>




Page: 1 2

Related medicine technology :

1. RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments
2. Gabapentin Shown Effective for Fibromyalgia Pain
3. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
4. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
5. Efficacy and Safety Profile of Basileas Alitretinoin for Severe Refractory Chronic Hand Eczema Confirmed by Data Shown at European Dermatology Congress
6. Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma
7. RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds Significant Promise for Treating Breast Cancer
8. Accelreon Pharmas ACE-031Shown to Increase Muscle Mass in Preclinical Studies
9. Cethromycin Shown Effective Against Anthrax in Study
10. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
11. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
Post Your Comments:
(Date:8/3/2015)... CITY, Calif., Aug. 3, 2015 AcelRx Pharmaceuticals, ... focused on the development and commercialization of innovative therapies ... business update and reported financial results for the three ... Business highlights include: , On July 23, 2015, ... adopted a positive opinion for Zalviso™ for the management ...
(Date:8/3/2015)... August 3, 2015 ReportsnReports.com ... research with 2020 forecasts as well as Global ... medical devices intelligence collection of its library. ... with 2020 forecasts spread across 164 pages, talking ... tables and figures is now available at ...
(Date:8/3/2015)... 3, 2015  Depomed, Inc. (NASDAQ: DEPO ) ... plc,s (NASDAQ: HZNP ) ("Horizon") announcement that it ... Board") set a record date to determine the shareholders ... The Depomed Board will review the request when it ... and contains the information required under Depomed,s bylaws, the ...
Breaking Medicine Technology:AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 2AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 3AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 4AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 5AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 6AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 7AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 8AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 9AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 10Medical Simulation Market to see 14% CAGR to 2019 2Medical Simulation Market to see 14% CAGR to 2019 3Medical Simulation Market to see 14% CAGR to 2019 4Medical Simulation Market to see 14% CAGR to 2019 5Medical Simulation Market to see 14% CAGR to 2019 6Depomed Comments on Horizon Pharma Announcement 2Depomed Comments on Horizon Pharma Announcement 3Depomed Comments on Horizon Pharma Announcement 4Depomed Comments on Horizon Pharma Announcement 5Depomed Comments on Horizon Pharma Announcement 6
... Sigma-Aldrich Corporation (Nasdaq: SIAL ) will be presenting ... 31st Annual Cowen and Company Healthcare Conference on Tuesday, March ... presenting at 10:15 AM (EST). Barclays Capital 2011 Global ... Hotel, Miami, FL, presenting at 10:15 AM (EDT). ...
... SPRING, Md., March 4, 2011 New data suggest ... increase the risk for the birth defects cleft lip ... use the medication during pregnancy, the U.S. Food and ... ) Before prescribing topiramate, approved to treat ...
Cached Medicine Technology:FDA: Risk of Oral Birth Defects in Children Born to Mothers Taking Topiramate 2FDA: Risk of Oral Birth Defects in Children Born to Mothers Taking Topiramate 3
(Date:8/4/2015)... ... August 04, 2015 , ... The goal of looking ... the desire for invasive surgery to achieve this ideal is not. But minimally invasive ... crave without the high cost or lengthy recovery time, according to Valerie Goldburt, ...
(Date:8/4/2015)... ... August 04, 2015 , ... Nathan’s Famous was recently ... small, medium, and large businesses making an impact in their industry. Andrew Tropeano, the ... how the famous hot dog maker now offers a 50% Reduced Fat All-Beef ...
(Date:8/4/2015)... ... August 04, 2015 , ... IN AMERICA and the program's ... depression. Depression affects millions of Americans every single year. To help people obtain ... viewers with the latest segment produced with the assistance of several top medical ...
(Date:8/4/2015)... KS (PRWEB) , ... August 04, 2015 , ... ... today their partnership to make the Isabel Symptom Checker available to all users ... consumers a mechanism to check their symptoms in an easy, intuitive method, provides ...
(Date:8/3/2015)... ... 04, 2015 , ... Keeping strong to their ongoing commitment ... today announced extra savings on Florida Physical Therapy continuing education packages. ... on Physical Therapy Flex packages by entering the promo code "FL229" ...
Breaking Medicine News(10 mins):Health News:Considering fillers, tighteners or laser resurfacing? 2Health News:Considering fillers, tighteners or laser resurfacing? 3Health News:Considering fillers, tighteners or laser resurfacing? 4Health News:Celebrate Summer with Nathan’s Famous Original Selfie Sweepstakes 2Health News:Celebrate Summer with Nathan’s Famous Original Selfie Sweepstakes 3Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 2Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 3Health News:Elite Online CE Provider Offers Discounted Flexible Packages to Meet Florida Physical Therapy Continuing Education Requirements 2
... , , ... ViroPharma Incorporated (Nasdaq: VPHM ... Committee supports the FDA,s Office of Generic Drugs (OGD) draft guidelines ... used to treat severe, often life-threatening bacterial infections of the gastrointestinal ...
... , , ALISO VIEJO, Calif., Aug. ... ), a premier anatomic pathology and molecular testing services resource for pathologists, ... quarter and six months ended June 30, 2009. Financial results included ... versus the second quarter of 2008, and a 43 percent increase in ...
... 4 /PRNewswire-FirstCall/ - Covidien (NYSE: COV ), a ... Inc. (TSX:NRI), a Canadian drug development company, today announced ... set a new action date under the Prescription Drug ... solution 1.5% w/w of November 4, 2009. , During ...
... delivery was vaginal or C-section doesn,t matter, study finds ... anesthesia during a Cesarean delivery doesn,t increase the risk ... , "We found that the incidence of learning disabilities ... those who were delivered via C-section but with general ...
... 5 years after the attacks, but asthma rates have steadily ... People directly exposed to the horrors of the Sept. 11, ... City were reporting new symptoms of post-traumatic stress as long ... study has found. , In fact, by 2006-2007, more people ...
... Petition drive by National Center ... captures 1 million signatures , , WASHINGTON, Aug. 4 ... today the 1 millionth signature on their joint "Free Our Health Care ... health care system. , , The millionth signature milestone comes ...
Cached Medicine News:Health News:ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride 2Health News:ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride 3Health News:ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride 4Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 2Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 3Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 4Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 5Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 6Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 7Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 8Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 9Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 10Health News:FDA extends review of Pennsaid(R) diclofenac sodium topical solution 2Health News:FDA extends review of Pennsaid(R) diclofenac sodium topical solution 3Health News:No Link Found Between Birth Anesthesia and Learning Issues 2Health News:For Many, 9/11-Linked Trauma Emerged Years Later 2Health News:For Many, 9/11-Linked Trauma Emerged Years Later 3Health News:One Million Americans - and Counting - Come Out Against President Obama's Health Care Plan 2Health News:One Million Americans - and Counting - Come Out Against President Obama's Health Care Plan 3
... OraQuick is an FDA ... venipuncture whole blood test used ... of HIV-1 infection. This CLIA ... presence of antibodies to HIV-1, ...
... Mononucleosis test is designed to detect ... plasma or whole blood. The QuickVue+ ... of bovine erythrocytes which give a ... extracts prepared from sheep and horse ...
... available point-of-care diagnostic test that can reliably ... A and B. The test uses a ... that assists viral replication by promoting the ... The ZstatFlu substrate is labeled with a ...
The NOW Flu A test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results and tre...
Medicine Products: